Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma

NCT01075113 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01075113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2010
Completion date
July 18, 2019
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer